retatrutide weight loss study ๐จ Today, retatrutide, the GIP/GLP-1/glucagon triple agonist, just delivered TRIUMPH-2 top-line results. A in those with concurrent obesity and type 2 diabetes. ๐ Mean body change at 80 weeks: โฌ๏ธ Lilly's triple agonist achieves 16.8%
Pay in 4 interest-free payments of $5.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 8 - Aug 13











-1.jpg&w=1200&q=75)















